| 000 | 017540000a22003370004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223024915.0 | ||
| 008 | 070526s2007 ua a f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.03.Ph.D.2007.Hi.E | ||
| 100 | 0 | _aHisham Abdelaziz Morsi | |
| 245 | 1 | 0 |
_aExpression of BCR\\ABL fusion transcript and its product protien p210 , in cells derived from patients of chronic myeloid leukemia (CML) , de novo and after treatment / _cHisham Abdelaziz Morsi ; Supervised Magda M.Assem , Nayera H.Elshakankiry , Sonya F.Arsanyos , Nahla A.Bahgat |
| 246 | 1 | 5 | _aوجود جين ال ب س ر و البروتين الناتج عنة فى خلايا دم مرضى سرطان الدم الميلودى المزمن فى الحالات الجديدة و بعد العلاج |
| 260 |
_aCairo : _bHisham Abdelaziz Morsi , _c2007 |
||
| 300 |
_a129P. : _bill ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology | ||
| 520 | _aOne important goal in CML is to monitor the level of BCR - ABL fusion gene and their activity during treatment molecular analysis can be performed on blood samples and are therfore much easier to than cytogenetic analysis of marrow cell metaphases | ||
| 530 | _aIssued Also as CD | ||
| 653 | 4 | _aChronic Myeloid leukemia (CML) | |
| 653 | 4 | _aExpression of BCR\\ABL | |
| 700 | 0 |
_aMagda Mahmoud Assem , _eSupervisor |
|
| 700 | 0 |
_aNayera Hamdy Elshakankiry , _eSupervisor |
|
| 700 | 0 |
_aSonya Fahmy Arsanyos , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aNazla _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c1616 _d1616 |
||